Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
keytruda
5
×
merck
national
5
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
5
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
5
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
fda
life sciences
biotech
cancer
pembrolizumab
roche
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
What
cancer
american
annual
based
best
bio
clinical
conference
continue
crash
debate
esmo
european
healthcare
industry
kind
medical
nash
oncology
people
pharmaceutical
policy
politicians
pressure
roundup
scalps
society
trump’s
u.s
approved
ash
barcelona
breast
cancer's
data
december's
deeper
dna
drug
fda
Language
unset
Current search:
keytruda
×
national
×
" seattle blog main "
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front